LEF1 and breast carcinoma: Likewise, LiCl enhanced breast cancer cell motility; but the enhancement could be eliminated by knocking down FMOD, or individual components of the β-cat/TCF4/LEF1 transcriptional complex, or by inhibiting HDAC6 with Trichostatin A (TSA) (Figures S1A, B).